Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnosis Center for Deafness | RCV002051749 | SCV001984974 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | criteria provided, single submitter | clinical testing | ||
Shenzhen Maternity and Child Healthcare Hospital, |
RCV002051749 | SCV004171061 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV003558850 | SCV004298177 | pathogenic | not provided | 2023-08-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1297080). Disruption of this splice site has been observed in individual(s) with nonsyndromic deafness (PMID: 26011067, 33597575). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 59 of the MYO15A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MYO15A are known to be pathogenic (PMID: 17546645). |
Deafness Molecular Diagnostic Center, |
RCV002051749 | SCV001949931 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | no assertion criteria provided | case-control |